| Identification | Back Directory | [Name]
Thalidomide-linker 15 | [CAS]
2376990-31-5 | [Synonyms]
Thalidomide-linker 15
-oxyacetamide-alkylC6-amine
Thalidomide-O-amido-C6-NH2 hydrochloride
N-(6-Aminohexyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide hydrochloride
ThalidomideOamidoC6NH2 hydrochloride,Inhibitor,inhibit,E3 Ligase Ligand-Linker Conjugates,Thalidomide-O-amido-C-6-NH2 hydrochloride,Thalidomide O amido C6 NH2 hydrochloride | [Molecular Formula]
C21H27ClN4O6 | [MDL Number]
MFCD32692986 | [MOL File]
2376990-31-5.mol | [Molecular Weight]
466.92 |
| Hazard Information | Back Directory | [Uses]
Thalidomide-O-amido-C6-NH2 hydrochloride, a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker, can be used in the synthesis of PROTACs[1]. | [IC 50]
Cereblon | [storage]
Store at -20°C | [References]
[1] Bradner J, et al. Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses. WO 2017024318 A1 |
|
| Company Name: |
Abosyn
|
| Tel: |
0512-69561983 13914027025 |
| Website: |
abosyn.cn/ |
|